Menu

CVS Health said drugmaker 340B contract pharmacy restrictions contributed to a decline in the company's pharmacy services revenue.

CVS Cites 340B Contract Pharmacy Restrictions in 19% Income Drop in Its Pharmacy Services

May 16, 2024 Rich Daly, Editor in Chief Views

CVS Health recently cited drug manufacturers’ contract pharmacy restrictions as one of the causes for a 19% year-over-year income decline [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Rich Daly